Literature DB >> 8264420

Cytomegalovirus IgM antibody detection: comparison of five assays.

Y J Kraat1, F S Stals, M P Landini, C A Bruggeman.   

Abstract

Human Cytomegalovirus (CMV) infection can result in a dramatic disease in immunosuppressed patients. For effective treatment sensitive and specific procedures are required for prompt and early diagnosis of active CMV infection. In the present study five different serological assays were used for detection of CMV-specific immunoglobulin M antibodies (IgM) in 78 sera, obtained from patients with a clinical suspicion of CMV infection. In addition, sequential sera, obtained from renal transplant recipients who experienced a primary CMV infection, were analysed by the five IgM detection assays. The assays used were two enzyme-linked immunosorbent assays (ELISA): the Vironostika CMV ELISA from Organon Teknika (ELISA-1) and the Monosan CMV ELISA from Sanbio (ELISA-2), the CMV microparticle enzyme immunoassay (MEIA) from Abbott and two Western-(immuno)blotting techniques using purified CMV structural viral proteins of the AD169 strain (IB-AD169) and the major non structural DNA binding protein of 52 kiloDalton (IB-Rp52) as antigenic material. The results of the assays were compared to each other with respect to sensitivity, specificity and overall agreement, as well as incidence of false positive and false negative results. Although the MEIA gave the highest sensitivity, the ELISA-1 combined a high sensitivity with a high specificity and therefore appears the most suitable method for determination of active CMV infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8264420

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  4 in total

1.  Measurement of the sensitivity of different commercial assays in the diagnosis of CMV infection in pregnancy.

Authors:  M Gentile; C Galli; P Pagnotti; P Di Marco; S Tzantzoglou; F Bellomi; M L Ferreri; C Selvaggi; G Antonelli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-04-10       Impact factor: 3.267

2.  Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer.

Authors:  G T Maine; R Stricker; M Schuler; J Spesard; S Brojanac; B Iriarte; K Herwig; T Gramins; B Combs; J Wise; H Simmons; T Gram; J Lonze; D Ruzicki; B Byrne; J D Clifton; L E Chovan; D Wachta; C Holas; D Wang; T Wilson; S Tomazic-Allen; M A Clements; G L Wright; T Lazzarotto; A Ripalti; M P Landini
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

3.  Development of a new cytomegalovirus (CMV) immunoglobulin M (IgM) immunoblot for detection of CMV-specific IgM.

Authors:  T Lazzarotto; A Ripalti; G Bergamini; M C Battista; P Spezzacatena; F Campanini; P Pradelli; S Varani; L Gabrielli; G T Maine; M P Landini
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

4.  Evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin M.

Authors:  Jiajun Zhang; Junchuan Li; Youshan Zhang; Hongyu Zhu; Qing Ma; Gang Hang
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.